Recent Updates
Recently added Catalysts
ALVO

Alvotech submits its application for admission of the company s shares to trading on Nasdaq Iceland Main Market Alvotech S.A. ( Alvotech ) has submitted its application to Nasdaq Iceland for admission of its shares for t

Key Takeaway: Alvotech submits its application for admission of the company s shares to trading on Nasdaq Iceland Main Market Alvotech S.A. ( Alvotech ) has submitted its application to Nasdaq Iceland for admission of its shares for trading on the Nasdaq Iceland Main Market under the ticker
Price reaction · baseline $6.3 (2022-11-30 close) · hit after-hours · 1 other ALVO headline(s) in the window, move may be shared
day 0 close
-2.4%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+128%
120-day peak, hindsight
Typical move
13.8%
average across 7 past catalysts
Lead asset
Stelara
Phase 3 · Psoriasis

Full Press Release Details

Alvotech submits its application for admission of the company s shares to trading on Nasdaq Iceland Main Market
Alvotech S.A. ( Alvotech ) has submitted its application to Nasdaq Iceland for admission of its shares for trading on the Nasdaq Iceland Main Market
under the ticker symbol ALVO . The application awaits approval from Nasdaq Iceland.
Alvotech s shares are currently listed on the Nasdaq
Stock Market in the U.S. and on the Nasdaq First North Growth Market under the ticker symbol ALVO . Alvotech s shares were admitted to trading in the U.S. on June 16, 2022 and in Iceland on June 23,
On 12 August 2022, Alvotech announced that the Board of Directors had approved a plan to move its share listing to the Nasdaq Main
For further information contact
Alvotech Investor Relations and Global Communication
alvotech.ir[at]alvotech.com
Last updated: Dec 1, 2022